TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BiolacUm AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
609
|
789 | |
| Financial expenses |
2,533
|
5,297 | |
| Earnings before taxes |
-2,278
|
4,411 | |
| EBITDA |
249
|
548 | |
| Total assets |
5,355
|
7,149 | |
| Current assets |
606
|
506 | |
| Current liabilities |
50
|
18 | |
| Equity capital |
5,096
|
6,939 | |
| - share capital |
101
|
95 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
95.2%
|
97.1% | |
| Turnover per employee |
609
|
789 | |
| Profit as a percentage of turnover |
-374.1%
|
559.1% | |
| Return on assets (ROA) |
4.8%
|
135.8% | |
| Current ratio |
1212.0%
|
2811.1% | |
| Return on equity (ROE) |
-44.7%
|
63.6% | |
| Change turnover |
-236
|
141 | |
| Change turnover % |
-34%
|
-28%
|
22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.